Dr Fiona Walter
Position: Group Leader
Personal home page: http://www.phpc.cam.ac.uk/people/pcu-group/pcu-senior-academic-staff/fiona-walter/
PubMed journal articles - click here
Dr Fiona Walter is pleased to consider applications from prospective PhD students.
Fiona’s portfolio of research is based in primary care, and focuses on the cancer continuum, including prevention, screening, early detection and diagnostic pathways. She co-leads the CanTest Collaborative, and CRUK-funded programme of research and capacity-building. Her research methods are wide ranging and include qualitative and mixed methods research, randomised controlled trials, cohort studies, and systematic reviews. Current projects are investigating skin, colorectal, ovarian, pancreatic, brain and oesophago-gastric cancer.
Symplectic Elements feed provided by Research Information, University of Cambridge
1. Walter FM, Thompson MJ, Wellwood I, et al. The CanTest Framework for evaluating diagnostic strategies for early detection of cancer in primary care. BMC Cancer, 2019 May 17;19:586. doi: 10.1186/s12885-019-5746-6.
2. Walter FM, Joannides A, Penfold C, et al. Missed opportunities for diagnosing brain tumours in primary care? Findings from a qualitative study. Brit J Gen Pract, 2019 Mar 11;69(681):e224-235. doi: 10.3399/bjgp19X701861.
3. Barclay ME, Lyratzopoulos G, Walter FM, et al. Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study. Thorax, 2019 Feb 18;74(5):466-472. doi: 10.1136/thoraxjnl-2018-212456.
4. Emery JD, Murray SR, Walter FM, et al. The CHEST Australia Trial: a randomised controlled trial of an intervention to reduce time to consult with symptoms of lung cancer. Thorax, 2019 Apr;74(4):362-370. doi: 10.1136/thoraxjnl-2018-212506.
5. Rubin G, Walter FM, Emery J, de Wit N. Re-imagining the diagnostic pathway for gastro-intestinal cancer. Nature Reviews Gastroenterol Hepatol 2018 Mar;15(3):181-188. doi: 10.1038/ nrgastro.2018.1. Epub 2018 Feb 7. Review.
6. Walter FM, Mills K, Mendonca S, et al. Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study. Lancet Gastroenterology and Hepatology, 2016;1(4):298-306. doi: 10.1016/S2468-1253(16)30079-6.
7. Walter FM, Emery JD, Mendonca S, et al. Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study. Brit J Cancer, 2016;115(5):533-541. doi: 10.1038/bjc.2016.221.
8. Hamilton W, Walter FM, Rubin G, Neal RD. Improving early diagnosis of symptomatic cancer. Nature Reviews Clin Oncol, 2016;13(12):740-749. doi: 10.1038/nrclinonc.2016.109.
9. Usher-Smith JA, Emery J, Hamilton W, Griffin S, Walter FM. Risk prediction tools for cancer in primary care. Br J Cancer, 2015;113(12):1645-1650. doi: 10.1038/bjc.2015.409.
10. Rubin G, Berendsen A, …Walter FM, et al. The expanding role of primary care in cancer control. Lancet Oncol, 2015 Sep;16(12):1231-1272. doi: 10.1016/S1470-2045(15)00205-3.
11. Walter FM, Rubin G, Bankhead C, et al. First symptoms and other factors associated with time to presentation and diagnosis and stage at diagnosis of lung cancer: a prospective cohort study. Brit J Cancer, 2015 Mar 31;112:S6-S13. doi: 10.1038/bjc.2015.30. PMID: 25734397.
12. Walter FM, Morris HC, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. Brit Med J, 2012;345:e4110.
13. Weller D, Vedsted P, Rubin G, Walter FM, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer, 2012;106(7):1262-1267.